J
John T. Reilly
Researcher at Royal Hallamshire Hospital
Publications - 125
Citations - 11269
John T. Reilly is an academic researcher from Royal Hallamshire Hospital. The author has contributed to research in topics: Myelofibrosis & Essential thrombocythemia. The author has an hindex of 49, co-authored 125 publications receiving 10647 citations.
Papers
More filters
Journal ArticleDOI
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment.
Francisco Cervantes,Brigitte Dupriez,Arturo Pereira,Francesco Passamonti,John T. Reilly,Enrica Morra,Alessandro M. Vannucchi,Ruben A. Mesa,Jean Loup Demory,Giovanni Barosi,Elisa Rumi,Ayalew Tefferi +11 more
TL;DR: In 409 patients with assessable metaphases, cytogenetic abnormalities were associated with shorter survival, but their independent contribution to prognosis was restricted to patients in the intermediate-risk groups.
Journal ArticleDOI
Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.
Ayalew Tefferi,Juergen Thiele,Attilio Orazi,Hans Michael Kvasnicka,Tiziano Barbui,Curtis A. Hanson,Giovanni Barosi,Srdan Verstovsek,Gunnar Birgegård,Ruben A. Mesa,John T. Reilly,Heinz Gisslinger,Alessandro M. Vannucchi,Francisco Cervantes,Guido Finazzi,Ronald Hoffman,D. Gary Gilliland,Clara D. Bloomfield,James W. Vardiman +18 more
TL;DR: In this paper, the authors proposed a revision of the current World Health Organization (WHO) diagnostic criteria for polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF), which was subsequently presented by an international expert panel of pathologists and clinical investigators in myeloproliferative disorders.
Journal ArticleDOI
Hydroxyurea Compared with Anagrelide in High-Risk Essential Thrombocythemia
Claire N. Harrison,Peter J. Campbell,Georgina Buck,Keith Wheatley,Clare L. East,David Bareford,Bridget S. Wilkins,van der Walt Jd,John T. Reilly,Andrew Grigg,Paula A. Revell,Woodcock Be,Anthony R. Green +12 more
TL;DR: Hydxyurea plus low-dose aspirin is superior to anagrelideplus low- dose aspirin for patients with essential thrombocythemia at high risk for vascular events.
Journal ArticleDOI
Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment.
Giovanni Barosi,Ruben A. Mesa,Juergen Thiele,Francisco Cervantes,Peter J. Campbell,Srdan Verstovsek,Brigitte Dupriez,Ross L. Levine,Francesco Passamonti,Jason Gotlib,John T. Reilly,Alessandro M. Vannucchi,C A Hanson,Lawrence A. Solberg,Attilio Orazi,Ayalew Tefferi +15 more
TL;DR: Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myel ofibrosis research and treatment.
Journal ArticleDOI
Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia.
TL;DR: This study reports, for the first time, point mutations in the human FLT3 gene that, because of their homology with other class III receptor tyrosine kinase mutations, probably result in constitutive activation of the receptor.